NCT02223481View on ClinicalTrials.gov

Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

May 31, 1998

Primary Completion Date

September 30, 1999

Conditions
Hypertension, Pulmonary
Interventions
DRUG

Terbogrel low dose

DRUG

Terbogrel high dose

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY